Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched - TCTMD

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched  TCTMD

HOLLYWOOD, FL—December 6, 2018, will long loom large in the minds of endovascular experts as the moment when a meta-analysis offered up a startling ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more